Indivior receives settlement approval for antitrust litigation

29th Feb 2024 09:47

(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.

Indivior said on Thursday that on 27 February, the United States District Court for the Eastern District of Pennsylvania entered an order granting final judgement and order of dismissal approving its direct purchaser class settlement and dismissing direct purchaser class claims.

The FTSE 250-listed group noted that the ruling, which follows a $385.0m settlement agreement in October 2023, now concludes the antitrust multi-district litigation .

As of 0945 GMT, Indivior shares were up 0.99% at 1,736.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Risers

Share	Price	Change
Eco Buildings (ECOB)	8.00	18.52%
Ixico (IXI)	11.25	12.5%
SIMEC Atlantis Energy (SAE)	1.70	9.68%
Skinbiotherap. (SBTX)	15.625	9.65%
Shield Thera (STX)	3.00	9.43%

Top Fallers

Share	Price	Change
Electric Guitar (ELEG)	0.21	-35.38%
UK Oil & Gas (UKOG)	0.02525	-25.88%
Woodbois (WBI)	0.215	-25.42%
Westmount Engy. (WTE)	0.90	-21.74%
Caledonian Tst. (CNN)	55.00	-21.43%

Top By Volume

Share	Price	Volume
UK Oil & Gas (UKOG)	0.02525	1,026,649,454
Tower Resources (TRP)	0.028	931,657,265
Mosman Oil Gas (MSMN)	0.041	296,810,199
Nativo Resources (NTVO)	0.0023	292,393,015
Oracle Power (ORCP)	0.0132	214,240,120

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.